Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

OBJECTIVE: Anxious depression is associated with greater chronicity, higher severity of symptoms, more severe functional impairment, and poor response to drug treatment. However, evidence for first-choice antidepressants in patients with anxious depression is limited. This study aimed to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Cheolmin, Jeon, Sang Won, Lee, Seung-Hoon, Pae, Chi-Un, Hong, Narei, Lim, Hyun Kook, Patkar, Ashwin A., Masand, Prakash S., An, Hyonggin, Han, Changsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889909/
https://www.ncbi.nlm.nih.gov/pubmed/36700320
http://dx.doi.org/10.9758/cpn.2023.21.1.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889909/
https://www.ncbi.nlm.nih.gov/pubmed/36700320
http://dx.doi.org/10.9758/cpn.2023.21.1.135

Ejemplares similares